The JAMA AI Summit, organized by a national workgroup featuring experts, including several from Kaiser Permanente’s Division of Research, emphasized the dual potential of artificial intelligence (AI) in healthcare. The group’s report, published on October 13, highlighted the need for a structured ecosystem to evaluate the benefits and risks of AI in health applications. Led by investigators like Vincent Liu, MD, MS, the workgroup identified critical recommendations: engaging end-users in AI tool development, promoting effective evaluation methods, creating robust data infrastructures, and establishing incentives for improvement. Kristine Lee, MD, underscored the necessity of addressing operational, ethical, and logistical challenges presented by AI’s rapid evolution. The report reflects a consensus that while AI has transformative potential, its safety and efficacy must be consistently assessed to enhance patient care and clinician capabilities. For further details on DOR’s impactful research initiatives, visit their website or follow @KPDOR.
Source link
